NEO
NeoGenomics IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$1.20B
P/E Ratio
—
EPS
$-0.79
Beta
1.80
52W High
$13.74
52W Low
$4.72
50-Day MA
$8.32
200-Day MA
$9.63
Dividend Yield
—
Profit Margin
-13.30%
Forward P/E
222.22
PEG Ratio
2.09
About NeoGenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
Fundamentals
| Revenue (TTM) | $745.97M |
| Gross Profit (TTM) | $321.51M |
| EBITDA | $4.27M |
| Operating Margin | -9.34% |
| Return on Equity | -11.60% |
| Return on Assets | -2.64% |
| Revenue/Share (TTM) | $5.80 |
| Book Value | $6.49 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | 1.61 |
| EV/Revenue | 1.942 |
| EV/EBITDA | -27.92 |
| Quarterly Earnings Growth (YoY) | 130.60% |
| Quarterly Revenue Growth (YoY) | 11.10% |
| Shares Outstanding | $130.21M |
| Float | $118.45M |
| % Insiders | 1.93% |
| % Institutions | 108.56% |
Historical Volatility
HV 10-Day
51.03%
HV 20-Day
47.48%
HV 30-Day
51.99%
HV 60-Day
51.23%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($15.06 target)
2
Strong Buy4
Buy7
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026